2023. Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 3-year Analysis of the KEEPsAKE 1 and 2 Trials. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s249. DOI:https://doi.org/10.25251/skin.7.supp.249.